02:05 PM EDT, 03/13/2025 (MT Newswires) -- Health care stocks fell Thursday afternoon with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.6%.

The iShares Biotechnology ETF (IBB) dropped 1.1%.

In sector news, Mallinckrodt and Endo are set to merge in a deal valued at $6.7 billion in cash and stock with the drug makers set to list shares of the new firm on the New York Stock Exchange.

In corporate news, Lifeward ( LFWD ) shares jumped 18%. The US Food and Drug Administration cleared ReWalk 7, the newest version of the company's personal exoskeleton device.

ImmunoPrecise Antibodies ( IPA ) shares rose 11% after the company announced a partnership with an undisclosed biotech firm to discover and develop antibody-drug conjugates and bispecific antibodies to treat cancer.

Dogwood Therapeutics ( DWTX ) shares tumbled 27% after the company launched a registered direct offering priced at $8.26 a share.